Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $184.43 | 9 | 65.1% |
| Education | $99.00 | 1 | 34.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Products, LP | $99.00 | 1 | $0 (2017) |
| Shire North American Group Inc | $73.26 | 1 | $0 (2017) |
| Insmed, Inc. | $43.65 | 3 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $37.63 | 3 | $0 (2018) |
| Mylan Institutional Inc. | $16.26 | 1 | $0 (2019) |
| Allergan Inc. | $13.63 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $73.54 | 5 | Insmed, Inc. ($43.65) |
| 2018 | $13.05 | 1 | Merck Sharp & Dohme Corporation ($13.05) |
| 2017 | $196.84 | 4 | Janssen Products, LP ($99.00) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/14/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Respiratory | ||||||
| 10/08/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/05/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Respiratory | ||||||
| 07/24/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Respiratory | ||||||
| 01/23/2019 | Mylan Institutional Inc. | Cimduo (Drug), Symfi, Symfi Lo | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Infectious Disease | ||||||
| 11/28/2018 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug), DIFICID, ZINPLAVA | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/20/2017 | Janssen Products, LP | PREZCOBIX (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 09/27/2017 | Shire North American Group Inc | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $73.26 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2017 | Merck Sharp & Dohme Corporation | CUBICIN RF (Drug), ZERBAXA, SIVEXTRO | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/14/2017 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug), DIFICID | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 839 | 2,252 | $348,165 | $165,237 |
| 2022 | 4 | 789 | 2,184 | $324,520 | $140,497 |
| 2021 | 4 | 1,065 | 2,881 | $430,848 | $190,054 |
| 2020 | 7 | 1,619 | 4,012 | $530,235 | $270,832 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 423 | 1,640 | $208,280 | $101,940 | 48.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 160 | 344 | $62,608 | $32,257 | 51.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 106 | 115 | $40,710 | $15,632 | 38.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 150 | 153 | $36,567 | $15,409 | 42.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 443 | 1,775 | $225,425 | $97,405 | 43.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 153 | 161 | $38,479 | $16,864 | 43.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 90 | 90 | $31,860 | $13,805 | 43.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 103 | 158 | $28,756 | $12,423 | 43.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 576 | 2,342 | $297,434 | $131,050 | 44.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 324 | 348 | $83,172 | $36,744 | 44.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 88 | 90 | $31,860 | $14,137 | 44.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 77 | 101 | $18,382 | $8,123 | 44.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 729 | 2,902 | $321,730 | $164,711 | 51.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 404 | 444 | $94,759 | $48,445 | 51.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 169 | 186 | $55,701 | $29,560 | 53.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 133 | 186 | $29,100 | $14,941 | 51.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 129 | 211 | $22,999 | $10,636 | 46.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 44 | 72 | $5,220 | $2,228 | 42.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 11 | 11 | $726.00 | $310.82 | 42.8% |
About Dr. Razi Syed, MD
Dr. Razi Syed, MD is a Infectious Disease healthcare provider based in Toledo, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2008. The National Provider Identifier (NPI) number assigned to this provider is 1255594420.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Razi Syed, MD has received a total of $283.43 in payments from pharmaceutical and medical device companies, with $73.54 received in 2019. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($184.43).
As a Medicare-enrolled provider, Syed has provided services to 4,312 Medicare beneficiaries, totaling 11,329 services with total Medicare billing of $766,620. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Toledo, OH
- Active Since 07/08/2008
- Last Updated 11/03/2023
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1255594420
Products in Payments
- PREZCOBIX (Drug) $99.00
- CUVITRU (Biological) $73.26
- Arikayce (Drug) $43.65
- NOXAFIL (Drug) $25.92
- Cimduo (Drug) $16.26
- AVYCAZ (Drug) $13.63
- CUBICIN RF (Drug) $11.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Toledo
Tanyanyiwa Chinyadza, M.d, M.D
Infectious Disease — Payments: $7,405
Dr. Arlette Aouad, M.d, M.D
Infectious Disease — Payments: $1,645
Dr. Luis Jauregui, M.d, M.D
Infectious Disease — Payments: $354.92
Dr. Caitlyn Hollingshead, Md, MD
Infectious Disease — Payments: $332.90
Michael Ellis, M.d, M.D
Infectious Disease — Payments: $85.64
Dr. Haig Donabedian, M.d, M.D
Infectious Disease